{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:18:45Z","timestamp":1790191125121,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Na<jats:sup>+<\/jats:sup>\u2013K<jats:sup>+<\/jats:sup>\u20132Cl<jats:sup>\u2212<\/jats:sup>cotransporter NKCC1 plays a role in neuronal Cl<jats:sup>\u2212<\/jats:sup>homeostasis secretion and represents a target for brain pathologies with altered NKCC1 function. Two main variants of NKCC1 have been identified: a full-length NKCC1 transcript (NKCC1A) and a shorter splice variant (NKCC1B) that is particularly enriched in the brain. The loop diuretic bumetanide is often used to inhibit NKCC1 in brain disorders, but only poorly crosses the blood-brain barrier. We determined the sensitivity of the two human NKCC1 splice variants to bumetanide and various other chemically diverse loop diuretics, using the<jats:italic>Xenopus<\/jats:italic>oocyte heterologous expression system. Azosemide was the most potent NKCC1 inhibitor (IC<jats:sub>50<\/jats:sub>s 0.246\u2009\u00b5M for hNKCC1A and 0.197\u2009\u00b5M for NKCC1B), being about 4-times more potent than bumetanide. Structurally, a carboxylic group as in bumetanide was not a prerequisite for potent NKCC1 inhibition, whereas loop diuretics without a sulfonamide group were less potent. None of the drugs tested were selective for hNKCC1B vs. hNKCC1A, indicating that loop diuretics are not a useful starting point to design NKCC1B-specific compounds. Azosemide was found to exert an unexpectedly potent inhibitory effect and as a non-acidic compound, it is more likely to cross the blood-brain barrier than bumetanide.<\/jats:p>","DOI":"10.1038\/s41598-018-27995-w","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T13:58:12Z","timestamp":1529935092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5391-555X","authenticated-orcid":false,"given":"Philip","family":"Hampel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"R\u00f6mermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-6600","authenticated-orcid":false,"given":"Nanna","family":"MacAulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"27995_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrn3819","volume":"15","author":"K Kaila","year":"2014","unstructured":"Kaila, K., Price, T. J., Payne, J. A., Puskarjov, M. & Voipio, J. Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat. Rev. Neurosci. 15, 637\u2013654 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"27995_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1152\/jn.00970.2011","volume":"108","author":"S Mao","year":"2012","unstructured":"Mao, S. et al. Molecular and functional expression of cation-chloride cotransporters in dorsal root ganglion neurons during postnatal maturation. J. Neurophysiol. 108, 834\u2013852 (2012).","journal-title":"J. Neurophysiol."},{"key":"27995_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ncpneuro0883","volume":"4","author":"KT Kahle","year":"2008","unstructured":"Kahle, K. T. et al. Roles of the cation-chloride cotransporters in neurological disease. Nat. Clin. Pract. Neurol. 4, 490\u2013503 (2008).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"27995_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/1073858412438697","volume":"18","author":"Y Ben Ari","year":"2012","unstructured":"Ben Ari, Y., Khalilov, I., Kahle, K. T. & Cherubini, E. The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders. Neuroscientist. 18, 467\u2013486 (2012).","journal-title":"Neuroscientist."},{"key":"27995_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","volume":"40","author":"Y Ben Ari","year":"2017","unstructured":"Ben Ari, Y. NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders. Trends Neurosci. 40, 536\u2013554 (2017).","journal-title":"Trends Neurosci."},{"key":"27995_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1020521308985","volume":"30","author":"M Haas","year":"1998","unstructured":"Haas, M. & Forbush, B. III. The Na-K-Cl cotransporters. J Bioenerg. Biomembr. 30, 161\u2013172 (1998).","journal-title":"J Bioenerg. Biomembr."},{"key":"27995_CR7","doi-asserted-by":"publisher","first-page":"F991","DOI":"10.1152\/ajprenal.00432.2014","volume":"307","author":"H Castrop","year":"2014","unstructured":"Castrop, H. & Schiessl, I. M. Physiology and pathophysiology of the renal Na-K-2Cl cotransporter (NKCC2). Am. J. Physiol Renal Physiol 307, F991\u2013F1002 (2014).","journal-title":"Am. J. Physiol Renal Physiol"},{"key":"27995_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","volume":"136","author":"G Burckhardt","year":"2012","unstructured":"Burckhardt, G. Drug transport by Organic Anion Transporters (OATs). Pharmacol. Ther. 136, 106\u2013130 (2012).","journal-title":"Pharmacol. Ther."},{"key":"27995_CR9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(25)30556-2","volume":"197","author":"MR Cohen","year":"1976","unstructured":"Cohen, M. R. et al. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog. J Pharmacol. Exp. Ther. 197, 697\u2013702 (1976).","journal-title":"J Pharmacol. Exp. Ther."},{"key":"27995_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","volume":"69","author":"W L\u00f6scher","year":"2013","unstructured":"L\u00f6scher, W., Puskarjov, M. & Kaila, K. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments. Neuropharmacology 69, 62\u201374 (2013).","journal-title":"Neuropharmacology"},{"key":"27995_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/epi.12620","volume":"55","author":"M Puskarjov","year":"2014","unstructured":"Puskarjov, M., Kahle, K. T., Ruusuvuori, E. & Kaila, K. Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures. Epilepsia 55, 806\u2013818 (2014).","journal-title":"Epilepsia"},{"key":"27995_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.02.006","volume":"117","author":"K R\u00f6mermann","year":"2017","unstructured":"R\u00f6mermann, K. et al. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain. Neuropharmacology 117, 182\u2013194 (2017).","journal-title":"Neuropharmacology"},{"key":"27995_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","volume":"14","author":"RM Pressler","year":"2015","unstructured":"Pressler, R. M. et al. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial. Lancet Neurol. 14, 469\u2013477 (2015).","journal-title":"Lancet Neurol."},{"key":"27995_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.24124","volume":"75","author":"K T\u00f6llner","year":"2014","unstructured":"T\u00f6llner, K. et al. A novel prodrug-based strategy to increase effects of bumetanide in epilepsy. Ann. Neurol. 75, 550\u2013562 (2014).","journal-title":"Ann. Neurol."},{"key":"27995_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/epi.13346","volume":"57","author":"T Erker","year":"2016","unstructured":"Erker, T. et al. The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice. Epilepsia 57, 698\u2013705 (2016).","journal-title":"Epilepsia"},{"key":"27995_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/9713","volume":"22","author":"E Delpire","year":"1999","unstructured":"Delpire, E., Lu, J., England, R., Dull, C. & Thorne, T. Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat. Genet. 22, 192\u2013195 (1999).","journal-title":"Nat. Genet."},{"key":"27995_CR17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/sj.ki.5002434","volume":"72","author":"LP Rybak","year":"2007","unstructured":"Rybak, L. P. & Ramkumar, V. Ototoxicity. Kidney Int. 72, 931\u2013935 (2007).","journal-title":"Kidney Int."},{"key":"27995_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1006\/abio.2001.5398","volume":"298","author":"CR Vibat","year":"2001","unstructured":"Vibat, C. R., Holland, M. J., Kang, J. J., Putney, L. K. & O\u2019Donnell, M. E. Quantitation of Na+-K+-2Cl- cotransport splice variants in human tissues using kinetic polymerase chain reaction. Anal. Biochem. 298, 218\u2013230 (2001).","journal-title":"Anal. Biochem."},{"key":"27995_CR19","doi-asserted-by":"publisher","first-page":"C1267","DOI":"10.1152\/ajpcell.1997.273.4.C1267","volume":"273","author":"J Randall","year":"1997","unstructured":"Randall, J., Thorne, T. & Delpire, E. Partial cloning and characterization of Slc12a2: the gene encoding the secretory Na+-K+-2Cl- cotransporter. Am. J. Physiol 273, C1267\u2013C1277 (1997).","journal-title":"Am. J. Physiol"},{"key":"27995_CR20","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1523\/JNEUROSCI.1423-13.2014","volume":"34","author":"Y Morita","year":"2014","unstructured":"Morita, Y. et al. Characteristics of the cation cotransporter NKCC1 in human brain: alternate transcripts, expression in development, and potential relationships to brain function and schizophrenia. J. Neurosci. 34, 4929\u20134940 (2014).","journal-title":"J. Neurosci."},{"key":"27995_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00018-009-0218-9","volume":"67","author":"RA Fenton","year":"2010","unstructured":"Fenton, R. A. et al. Differential water permeability and regulation of three aquaporin 4 isoforms. Cell Mol Life Sci. 67, 829\u2013840 (2010).","journal-title":"Cell Mol Life Sci."},{"key":"27995_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1113\/jphysiol.2011.226316","volume":"590","author":"T Zeuthen","year":"2012","unstructured":"Zeuthen, T. & Macaulay, N. Cotransport of water by Na(+)-K(+)-2Cl(-) cotransporters expressed in Xenopus oocytes: NKCC1 versus NKCC2. J Physiol 590, 1139\u20131154 (2012).","journal-title":"J Physiol"},{"key":"27995_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/BF00587857","volume":"396","author":"E Schlatter","year":"1983","unstructured":"Schlatter, E., Greger, R. & Weidtke, C. Effect of \u201chigh ceiling\u201d diuretics on active salt transport in the cortical thick ascending limb of Henle\u2019s loop of rabbit kidney. Correlation of chemical structure and inhibitory potency. Pflugers Arch. 396, 210\u2013217 (1983).","journal-title":"Pflugers Arch."},{"key":"27995_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s004670050514","volume":"12","author":"SK Eades","year":"1998","unstructured":"Eades, S. K. & Christensen, M. L. The clinical pharmacology of loop diuretics in the pediatric patient. Pediatr. Nephrol. 12, 603\u2013616 (1998).","journal-title":"Pediatr. Nephrol."},{"key":"27995_CR25","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1345\/aph.1M177","volume":"43","author":"KA Wargo","year":"2009","unstructured":"Wargo, K. A. & Banta, W. M. A comprehensive review of the loop diuretics: should furosemide be first line? Ann. Pharmacother. 43, 1836\u20131847 (2009).","journal-title":"Ann. Pharmacother."},{"key":"27995_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1074248413497257","volume":"19","author":"GC Roush","year":"2014","unstructured":"Roush, G. C., Kaur, R. & Ernst, M. E. Diuretics: a review and update. J. Cardiovasc. Pharmacol. Ther. 19, 5\u201313 (2014).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"27995_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5049\/EBP.2015.13.1.17","volume":"13","author":"SW Oh","year":"2015","unstructured":"Oh, S. W. & Han, S. Y. Loop Diuretics in Clinical Practice. Electrolyte Blood Press 13, 17\u201321 (2015).","journal-title":"Electrolyte Blood Press"},{"key":"27995_CR28","doi-asserted-by":"publisher","first-page":"C284","DOI":"10.1152\/ajpcell.1994.266.1.C284","volume":"266","author":"W Suvitayavat","year":"1994","unstructured":"Suvitayavat, W. et al. Characterization of the endogenous Na(+)-K(+)-2Cl- cotransporter in Xenopus oocytes. Am. J Physiol 266, C284\u2013C292 (1994).","journal-title":"Am. J Physiol"},{"key":"27995_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yebeh.2016.03.021","volume":"59","author":"K Lykke","year":"2016","unstructured":"Lykke, K. et al. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A. Epilepsy Behav. 59, 42\u201349 (2016).","journal-title":"Epilepsy Behav."},{"key":"27995_CR30","unstructured":"Reilly, R. F. & Jackson, E. K. Goodman & Gilman\u2019s. The Pharmacological Basis of Therapeutics. 12th ed. Brunton, L. L., Chabner, B. A. & Knollmann, B. C. (eds), pp. 671\u2013719 (McGraw-Hill, New York, (2011)."},{"key":"27995_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/bdd.365","volume":"24","author":"OK Suh","year":"2003","unstructured":"Suh, O. K., Kim, S. H. & Lee, M. G. Pharmacokinetics and pharmacodynamics of azosemide. Biopharm. Drug Dispos. 24, 275\u2013297 (2003).","journal-title":"Biopharm. Drug Dispos."},{"key":"27995_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/bdd.2510160704","volume":"16","author":"SH Lee","year":"1995","unstructured":"Lee, S. H. & Lee, M. G. Stability, tissue metabolism, tissue distribution and blood partition of azosemide. Biopharm. Drug Dispos. 16, 547\u2013561 (1995).","journal-title":"Biopharm. Drug Dispos."},{"key":"27995_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199834010-00001","volume":"34","author":"H Knauf","year":"1998","unstructured":"Knauf, H. & Mutschler, E. Clinical pharmacokinetics and pharmacodynamics of torasemide. Clin. Pharmacokinet. 34, 1\u201324 (1998).","journal-title":"Clin. Pharmacokinet."},{"key":"27995_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/bdd.447","volume":"26","author":"DY Lee","year":"2005","unstructured":"Lee, D. Y. et al. Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats. Biopharm. Drug Dispos. 26, 173\u2013182 (2005).","journal-title":"Biopharm. Drug Dispos."},{"key":"27995_CR35","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","volume":"30","author":"C Brandt","year":"2010","unstructured":"Brandt, C., Nozadze, M., Heuchert, N., Rattka, M. & L\u00f6scher, W. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. J. Neurosci. 30, 8602\u20138612 (2010).","journal-title":"J. Neurosci."},{"key":"27995_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/clpt.1983.133","volume":"34","author":"DC Brater","year":"1983","unstructured":"Brater, D. C. & Anderson, S. Sites of action of tripamide. Clin. Pharmacol. Ther. 34, 79\u201385 (1983).","journal-title":"Clin. Pharmacol. Ther."},{"key":"27995_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00424-013-1370-5","volume":"466","author":"N Markadieu","year":"2014","unstructured":"Markadieu, N. & Delpire, E. Physiology and pathophysiology of SLC12A1\/2 transporters. Pflugers Arch. 466, 91\u2013105 (2014).","journal-title":"Pflugers Arch."},{"key":"27995_CR38","doi-asserted-by":"crossref","unstructured":"Alvarez-Leefmans, F. J. Cell physiology sourcebook. Fourth edition. Essentials of membrane biophysics. Sperelakis, N. (ed.), pp. 221\u2013259 (Academic Press, London, 2012).","DOI":"10.1016\/B978-0-12-387738-3.00015-9"},{"key":"27995_CR39","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1091\/mbc.e08-05-0478","volume":"19","author":"M Carmosino","year":"2008","unstructured":"Carmosino, M., Gimenez, I., Caplan, M. & Forbush, B. Exon loss accounts for differential sorting of Na-K-Cl cotransporters in polarized epithelial cells. Mol. Biol. Cell 19, 4341\u20134351 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"27995_CR40","doi-asserted-by":"publisher","first-page":"24556","DOI":"10.1074\/jbc.272.39.24556","volume":"272","author":"P Isenring","year":"1997","unstructured":"Isenring, P. & Forbush, B. III Ion and bumetanide binding by the Na-K-Cl cotransporter. Importance of transmembrane domains. J. Biol. Chem. 272, 24556\u201324562 (1997).","journal-title":"J. Biol. Chem."},{"key":"27995_CR41","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1073\/pnas.95.12.7179","volume":"95","author":"P Isenring","year":"1998","unstructured":"Isenring, P., Jacoby, S. C. & Forbush, B. III. The role of transmembrane domain 2 in cation transport by the Na-K-Cl cotransporter. Proc. Natl. Acad. Sci. USA 95, 7179\u20137184 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"27995_CR42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1085\/jgp.112.5.549","volume":"112","author":"P Isenring","year":"1998","unstructured":"Isenring, P., Jacoby, S. C., Chang, J. & Forbush, B. Mutagenic mapping of the Na-K-Cl cotransporter for domains involved in ion transport and bumetanide binding. J. Gen. Physiol 112, 549\u2013558 (1998).","journal-title":"J. Gen. Physiol"},{"key":"27995_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1095-6433(01)00420-2","volume":"130","author":"P Isenring","year":"2001","unstructured":"Isenring, P. & Forbush, B. Ion transport and ligand binding by the Na-K-Cl cotransporter, structure-function studies. Comp Biochem. Physiol A Mol. Integr. Physiol 130, 487\u2013497 (2001).","journal-title":"Comp Biochem. Physiol A Mol. Integr. Physiol"},{"key":"27995_CR44","doi-asserted-by":"publisher","first-page":"17308","DOI":"10.1074\/jbc.M112.356014","volume":"287","author":"S Somasekharan","year":"2012","unstructured":"Somasekharan, S., Tanis, J. & Forbush, B. Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1). J Biol. Chem. 287, 17308\u201317317 (2012).","journal-title":"J Biol. Chem."},{"key":"27995_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/002215549704500601","volume":"45","author":"JJ Crouch","year":"1997","unstructured":"Crouch, J. J., Sakaguchi, N., Lytle, C. & Schulte, B. A. Immunohistochemical localization of the Na-K-Cl co-transporter (NKCC1) in the gerbil inner ear. J. Histochem. Cytochem. 45, 773\u2013778 (1997).","journal-title":"J. Histochem. Cytochem."},{"key":"27995_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0378-5955(98)00022-7","volume":"118","author":"N Sakaguchi","year":"1998","unstructured":"Sakaguchi, N., Crouch, J. J., Lytle, C. & Schulte, B. A. Na-K-Cl cotransporter expression in the developing and senescent gerbil cochlea. Hear. Res. 118, 114\u2013122 (1998).","journal-title":"Hear. Res."},{"key":"27995_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/adt.2017.787","volume":"15","author":"S Gill","year":"2017","unstructured":"Gill, S. et al. A High-Throughput Screening Assay for NKCC1 Cotransporter Using Nonradioactive Rubidium Flux Technology. Assay. Drug Dev. Technol. 15, 167\u2013177 (2017).","journal-title":"Assay. Drug Dev. Technol."},{"key":"27995_CR48","doi-asserted-by":"publisher","first-page":"C139","DOI":"10.1152\/ajpcell.1980.238.3.C139","volume":"238","author":"HC Palfrey","year":"1980","unstructured":"Palfrey, H. C., Feit, P. W. & Greengard, P. cAMP-stimulated cation cotransport in avian erythrocytes: inhibition by \u201cloop\u201d diuretics. Am. J Physiol 238, C139\u2013C148 (1980).","journal-title":"Am. J Physiol"},{"key":"27995_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0006-291X(86)90566-8","volume":"134","author":"C Frelin","year":"1986","unstructured":"Frelin, C., Chassande, O. & Lazdunski, M. Biochemical characterization of the Na+\/K+\/Cl- co-transport in chick cardiac cells. Biochem. Biophys. Res. Commun. 134, 326\u2013331 (1986).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"27995_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF01869330","volume":"96","author":"SM O\u2019Grady","year":"1987","unstructured":"O\u2019Grady, S. M., Palfrey, H. C. & Field, M. Na-K-2Cl cotransport in winter flounder intestine and bovine kidney outer medulla: [3H] bumetanide binding and effects of furosemide analogues. J. Membr. Biol. 96, 11\u201318 (1987).","journal-title":"J. Membr. Biol."},{"key":"27995_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s004240100629","volume":"443","author":"M Glanville","year":"2001","unstructured":"Glanville, M., Kingscote, S., Thwaites, D. T. & Simmons, N. L. Expression and role of sodium, potassium, chloride cotransport (NKCC1) in mouse inner medullary collecting duct (mIMCD-K2) epithelial cells. Pflugers Arch. 443, 123\u2013131 (2001).","journal-title":"Pflugers Arch."},{"key":"27995_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00210-001-0521-y","volume":"365","author":"P Hannaert","year":"2002","unstructured":"Hannaert, P., Alvarez-Guerra, M., Pirot, D., Nazaret, C. & Garay, R. P. Rat NKCC2\/NKCC1 cotransporter selectivity for loop diuretic drugs. Naunyn Schmiedebergs Arch. Pharmacol. 365, 193\u2013199 (2002).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"27995_CR53","first-page":"805","volume":"41","author":"J Greven","year":"1991","unstructured":"Greven, J. Attenuation of azosemide\u2019s action in the loop of Henle of rat kidney by nonsteroidal anti-inflammatory drugs. Arzneimittelforschung. 41, 805\u2013808 (1991).","journal-title":"Arzneimittelforschung."},{"key":"27995_CR54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/BF00582640","volume":"407","author":"M Wittner","year":"1986","unstructured":"Wittner, M., Di Stefano, A., Schlatter, E., Delarge, J. & Greger, R. Torasemide inhibits NaCl reabsorption in the thick ascending limb of the loop of Henle. Pflugers Arch. 407, 611\u2013614 (1986).","journal-title":"Pflugers Arch."},{"key":"27995_CR55","doi-asserted-by":"publisher","first-page":"16237","DOI":"10.1074\/jbc.271.27.16237","volume":"271","author":"CM Gillen","year":"1996","unstructured":"Gillen, C. M., Brill, S., Payne, J. A. & Forbush, B. III. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family. J. Biol. Chem. 271, 16237\u201316244 (1996).","journal-title":"J. Biol. Chem."},{"key":"27995_CR56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1748-1716.2010.02099.x","volume":"199","author":"I Carota","year":"2010","unstructured":"Carota, I. et al. Localization and functional characterization of the human NKCC2 isoforms. Acta Physiol (Oxf) 199, 327\u2013338 (2010).","journal-title":"Acta Physiol (Oxf)"},{"key":"27995_CR57","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1074\/jbc.270.30.17977","volume":"270","author":"JA Payne","year":"1995","unstructured":"Payne, J. A. et al. Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon. J. Biol. Chem. 270, 17977\u201317985 (1995).","journal-title":"J. Biol. Chem."},{"key":"27995_CR58","doi-asserted-by":"publisher","first-page":"11295","DOI":"10.1074\/jbc.273.18.11295","volume":"273","author":"P Isenring","year":"1998","unstructured":"Isenring, P., Jacoby, S. C., Payne, J. A. & Forbush, B. III. Comparison of Na-K-Cl cotransporters. NKCC1, NKCC2, and the HEK cell Na-L-Cl cotransporter. J. Biol. Chem. 273, 11295\u201311301 (1998).","journal-title":"J. Biol. Chem."},{"key":"27995_CR59","doi-asserted-by":"publisher","first-page":"11004","DOI":"10.1074\/jbc.M110442200","volume":"277","author":"C Plata","year":"2002","unstructured":"Plata, C., Meade, P., Vazquez, N., Hebert, S. C. & Gamba, G. Functional properties of the apical Na+-K+-2Cl- cotransporter isoforms. J Biol. Chem. 277, 11004\u201311012 (2002).","journal-title":"J Biol. Chem."},{"key":"27995_CR60","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1111\/bph.13231","volume":"172","author":"K Lykke","year":"2015","unstructured":"Lykke, K. et al. Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of human NKCC2 variant A. Brit. J. Pharmacol. 172, 4469\u20134480 (2015).","journal-title":"Brit. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27995-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T09:08:07Z","timestamp":1751706487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27995-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["27995"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-27995-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"21 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9877"}}